While promising, these peptides remain experimental, highlighting the need for further studies to unlock their full potential in regenerative medicine
AOD-9604 Research Exclusions and Evidence Gaps AOD-9604 is a research compound with no FDA-approved indication for any patient population
Optic Labs supplies the blend strictly for laboratory research, development and analytical use not for human consumption, clinical or cosmetic application
Research shows both peptides are well tolerated, with very low rates of adverse events
swelling of your face, lips, tongue, or throat
For cats with inflammatory bowel disease, the most common recommended schedule for B12 injections is to give 250 micrograms per cat once a week for six weeks